Nicholas Galakatos, 10% Owner at AERIE PHARMACEUTICALS INC (AERI), bought 3,233,084 shares at $10.00 ($3.2M) on 2013-10-25, disclosed to the SEC on 2013-10-28.
Open-market purchase of $3.2M AERI by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,727,272 | $0 | 0.0% |
| 2 | $0.05 | 184,812 | $9K | 0.3% |
| 3 | $10.00 | 321,000 | $3.2M | 99.7% |
| Total | $1.00 avg | 3,233,084 | $3.2M | 100% |
| Filing → |
| FTSV | BUY | 2018-07-02 | $3.2M | — | Filing → |
| OPHT | SELL | 2016-01-13 | $197K | — | Filing → |
| OPHT | SELL | 2015-12-14 | $193K | — | Filing → |